MARKET

AGRX

AGRX

Agile
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.690
-0.050
-2.88%
Opening 14:29 11/22 EST
OPEN
1.760
PREV CLOSE
1.740
HIGH
1.770
LOW
1.660
VOLUME
966.87K
TURNOVER
--
52 WEEK HIGH
2.970
52 WEEK LOW
0.3500
MARKET CAP
100.21M
P/E (TTM)
-4.2438
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AGRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AGRX News

  • Daily Insider Ratings Round Up 11/18/19
  • Seeking Alpha - Article.1d ago
  • I, BCRX, AGRX and THMO among midday movers
  • Seeking Alpha - Article.3d ago
  • Agile: FDA Decision To Extend Twirla's PDUFA Date Provides Buying Opportunity
  • Seeking Alpha - Article.4d ago
  • Microcaps mostly among midday movers
  • Seeking Alpha - Article.11/15 17:58

More

Industry

Biotechnology & Medical Research
+1.64%
Pharmaceuticals & Medical Research
+0.78%

Hot Stocks

Name
Price
%Change

About AGRX

Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. The Company is focused in the development and commercialization of prescription contraceptive products. The Company has developed a transdermal patch technology, called Skinfusion. The Company's lead product candidate is Twirla, also known as AG200-15, is a combined hormonal contraceptive (CHC) patch. In addition to Twirla, the Company is developing a pipeline of other new transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide a shortened hormone-free interval, and AG890, which is a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Each of its product candidates utilizes its Skinfusion technology designed to deliver contraceptive-levels of hormones to the blood stream through the skin over a seven-day period.
More

Webull offers Agile Therapeutics Inc (AGRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.